204 related articles for article (PubMed ID: 24732803)
21. Modulation of the hepatic malonyl-CoA-carnitine palmitoyltransferase 1A partnership creates a metabolic switch allowing oxidation of de novo fatty acids.
Akkaoui M; Cohen I; Esnous C; Lenoir V; Sournac M; Girard J; Prip-Buus C
Biochem J; 2009 May; 420(3):429-38. PubMed ID: 19302064
[TBL] [Abstract][Full Text] [Related]
22. Novel role of the ER/SR Ca
Collins HE; Pat BM; Zou L; Litovsky SH; Wende AR; Young ME; Chatham JC
Am J Physiol Heart Circ Physiol; 2019 May; 316(5):H1014-H1026. PubMed ID: 30575437
[TBL] [Abstract][Full Text] [Related]
23. Liver-specific loss of long chain acyl-CoA synthetase-1 decreases triacylglycerol synthesis and beta-oxidation and alters phospholipid fatty acid composition.
Li LO; Ellis JM; Paich HA; Wang S; Gong N; Altshuller G; Thresher RJ; Koves TR; Watkins SM; Muoio DM; Cline GW; Shulman GI; Coleman RA
J Biol Chem; 2009 Oct; 284(41):27816-27826. PubMed ID: 19648649
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of mitochondrial β-oxidation by miR-107 promotes hepatic lipid accumulation and impairs glucose tolerance in vivo.
Bhatia H; Pattnaik BR; Datta M
Int J Obes (Lond); 2016 May; 40(5):861-9. PubMed ID: 26499439
[TBL] [Abstract][Full Text] [Related]
25. Structure and function of phosphatidylcholine transfer protein (PC-TP)/StarD2.
Kanno K; Wu MK; Scapa EF; Roderick SL; Cohen DE
Biochim Biophys Acta; 2007 Jun; 1771(6):654-62. PubMed ID: 17499021
[TBL] [Abstract][Full Text] [Related]
26. High-throughput screening identifies small molecule inhibitors of thioesterase superfamily member 1: Implications for the management of non-alcoholic fatty liver disease.
Krumm CS; Landzberg RS; Ramos-Espiritu L; Adura C; Liu X; Acuna M; Xie Y; Xu X; Tillman MC; Li Y; Glickman JF; Ortlund EA; Ginn JD; Cohen DE
Mol Metab; 2023 Dec; 78():101832. PubMed ID: 38403978
[TBL] [Abstract][Full Text] [Related]
27. Regulation of fatty acid trafficking in liver by thioesterase superfamily member 1.
Desai A; Alves-Bezerra M; Li Y; Ozdemir C; Bare CJ; Li Y; Hagen SJ; Cohen DE
J Lipid Res; 2018 Feb; 59(2):368-379. PubMed ID: 29208699
[TBL] [Abstract][Full Text] [Related]
28. Altered hepatic cholesterol metabolism compensates for disruption of phosphatidylcholine transfer protein in mice.
Wu MK; Cohen DE
Am J Physiol Gastrointest Liver Physiol; 2005 Sep; 289(3):G456-61. PubMed ID: 15845870
[TBL] [Abstract][Full Text] [Related]
29. PCB126-Induced Disruption in Gluconeogenesis and Fatty Acid Oxidation Precedes Fatty Liver in Male Rats.
Gadupudi GS; Klaren WD; Olivier AK; Klingelhutz AJ; Robertson LW
Toxicol Sci; 2016 Jan; 149(1):98-110. PubMed ID: 26396156
[TBL] [Abstract][Full Text] [Related]
30. Regulator of G protein signaling (RGS16) inhibits hepatic fatty acid oxidation in a carbohydrate response element-binding protein (ChREBP)-dependent manner.
Pashkov V; Huang J; Parameswara VK; Kedzierski W; Kurrasch DM; Tall GG; Esser V; Gerard RD; Uyeda K; Towle HC; Wilkie TM
J Biol Chem; 2011 Apr; 286(17):15116-25. PubMed ID: 21357625
[TBL] [Abstract][Full Text] [Related]
31. OXPHOS-Mediated Induction of NAD+ Promotes Complete Oxidation of Fatty Acids and Interdicts Non-Alcoholic Fatty Liver Disease.
Akie TE; Liu L; Nam M; Lei S; Cooper MP
PLoS One; 2015; 10(5):e0125617. PubMed ID: 25933096
[TBL] [Abstract][Full Text] [Related]
32. Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice.
Malloy VL; Perrone CE; Mattocks DA; Ables GP; Caliendo NS; Orentreich DS; Orentreich N
Metabolism; 2013 Nov; 62(11):1651-61. PubMed ID: 23928105
[TBL] [Abstract][Full Text] [Related]
33. Prevention of hepatic fibrosis with liver microsomal triglyceride transfer protein deletion in liver fatty acid binding protein null mice.
Newberry EP; Xie Y; Kennedy SM; Graham MJ; Crooke RM; Jiang H; Chen A; Ory DS; Davidson NO
Hepatology; 2017 Mar; 65(3):836-852. PubMed ID: 27862118
[TBL] [Abstract][Full Text] [Related]
34. Deletion of CaMKK2 from the liver lowers blood glucose and improves whole-body glucose tolerance in the mouse.
Anderson KA; Lin F; Ribar TJ; Stevens RD; Muehlbauer MJ; Newgard CB; Means AR
Mol Endocrinol; 2012 Feb; 26(2):281-91. PubMed ID: 22240810
[TBL] [Abstract][Full Text] [Related]
35. DEPP/DEPP1/C10ORF10 regulates hepatic glucose and fat metabolism partly via ROS-induced FGF21.
Li W; Ji M; Lin Y; Miao Y; Chen S; Li H
FASEB J; 2018 Oct; 32(10):5459-5469. PubMed ID: 29702025
[TBL] [Abstract][Full Text] [Related]
36. Mitochondrial Fatty Acid β-Oxidation Inhibition Promotes Glucose Utilization and Protein Deposition through Energy Homeostasis Remodeling in Fish.
Li LY; Li JM; Ning LJ; Lu DL; Luo Y; Ma Q; Limbu SM; Li DL; Chen LQ; Lodhi IJ; Degrace P; Zhang ML; Du ZY
J Nutr; 2020 Sep; 150(9):2322-2335. PubMed ID: 32720689
[TBL] [Abstract][Full Text] [Related]
37. Regulation of hepatic lipid deposition by phospholipid in large yellow croaker.
Cai Z; Mai K; Ai Q
Br J Nutr; 2017 Dec; 118(12):999-1009. PubMed ID: 29198193
[TBL] [Abstract][Full Text] [Related]
38. Thrombospondin 1 improves hepatic steatosis in diet-induced insulin-resistant mice and is associated with hepatic fat content in humans.
Bai J; Xia M; Xue Y; Ma F; Cui A; Sun Y; Han Y; Xu X; Zhang F; Hu Z; Liu Z; Liu Y; Cai G; Su W; Sun X; Wu H; Yan H; Chang X; Hu X; Bian H; Xia P; Gao J; Li Y; Gao X
EBioMedicine; 2020 Jul; 57():102849. PubMed ID: 32580141
[TBL] [Abstract][Full Text] [Related]
39. Ligand dependent interaction between PC-TP and PPARδ mitigates diet-induced hepatic steatosis in male mice.
Druzak SA; Tardelli M; Mays SG; El Bejjani M; Mo X; Maner-Smith KM; Bowen T; Cato ML; Tillman MC; Sugiyama A; Xie Y; Fu H; Cohen DE; Ortlund EA
Nat Commun; 2023 May; 14(1):2748. PubMed ID: 37173315
[TBL] [Abstract][Full Text] [Related]
40. Hepatic PTEN deficiency improves muscle insulin sensitivity and decreases adiposity in mice.
Peyrou M; Bourgoin L; Poher AL; Altirriba J; Maeder C; Caillon A; Fournier M; Montet X; Rohner-Jeanrenaud F; Foti M
J Hepatol; 2015 Feb; 62(2):421-9. PubMed ID: 25234947
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
